Showing results (51-60 of 66) with videos related to
Sort By:
Pageof 7
The Milbank Quarterly|June 29, 2010
EBM, HTA, and CER: clearing the confusionBryan R Luce, Michael Drummond, Bengt Jönsson, et al.International Journal of Technology Assessment in Health Care|January 12, 2010
Are Key Principles for improved health technology assessment supported and used by health technology assessment organizations?, Peter J Neumann, Michael F Drummond, et al.Journal of Comparative Effectiveness Research|November 19, 2013
Principles for planning and conducting comparative effectiveness researchBryan R Luce, Michael F Drummond, Robert W Dubois, et al.International Journal of Technology Assessment in Health Care|July 8, 2008
Key principles for the improved conduct of health technology assessments for resource allocation decisionsMichael F Drummond, J Sanford Schwartz, Bengt Jönsson, et al.Infection and Immunity|May 17, 2017
Microbiomes of Site-Specific Dental Plaques from Children with Different Caries StatusVincent P Richards, Andres J Alvarez, Amy R Luce, et al.Annals of Internal Medicine|June 9, 2016
Using Bayesian Adaptive Trial Designs for Comparative Effectiveness Research: A Virtual Trial ExecutionBryan R Luce, Jason T Connor, Kristine R Broglio, et al.Pharmacoepidemiology and Drug Safety|August 1, 2014
Characteristics and temporal trends in patient registries: focus on the life sciences industry, 1981-2012Karin Travers, Rachel H Sallum, Meghan D Burns, et al.Frontiers in Psychology|September 7, 2021
"He Fell in and That's How He Became a Fossil!": Engagement With a Storytelling Exhibit Predicts Families' Explanatory Science Talk During a Museum VisitMaureen A Callanan, Claudia L Castañeda, Graciela Solis, et al.Vaccine|May 9, 2008
Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United StatesBryan R Luce, Kristin L Nichol, Robert B Belshe, et al.Pharmacoeconomics|June 7, 1994
Recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer: an economic analysis of a randomised, double-blind, placebo-controlled trialB R Luce, J W Singer, J M Weschler, et al.Pageof 7